Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
128M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
15.7M
-
Shares change
-
+15.7M
-
Total reported value, excl. options
-
$340M
-
Value change
-
+$340M
-
Number of buys
-
46
-
Price
-
$21.70
Significant Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q4 2017
46 filings reported holding APLS - Apellis Pharmaceuticals, Inc. - Common Stock as of Q4 2017.
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.7M shares
of 128M outstanding shares and own 12.33% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LLC (3.77M shares), Sectoral Asset Management Inc (1.75M shares), Vivo Capital, LLC (1.46M shares), Hillhouse Capital Management, Ltd. (1.43M shares), EcoR1 Capital, LLC (1.14M shares), BlackRock Inc. (972K shares), CLOUGH CAPITAL PARTNERS L P (917K shares), RA CAPITAL MANAGEMENT, LLC (900K shares), JENNISON ASSOCIATES LLC (607K shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (513K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.